Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Human Mutation
|
September 5, 2003
Mutation spectrum of human SLC39A4 in a panel of patients with acrodermatitis enteropathica
Sébastien Küry, Monia Kharfi, Ridha Kamoun, et al.
Journal of Clinical Microbiology
|
January 9, 2015
Early detection of dengue virus by use of reverse transcription-recombinase polymerase amplification
Boon-Teong Teoh, Sing-Sin Sam, Kim-Kee Tan, et al.
Nanoscale
|
March 19, 2020
Inkjet-printed graphene Hall mobility measurements and low-frequency noise characterization
Gabriele Calabrese, Lorenzo Pimpolari, Silvia Conti, et al.
Patterns (New York, N.Y.)
|
September 10, 2025
A view of the sustainable computing landscape
Benjamin C Lee, David Brooks, Arthur van Benthem, et al.
Stem Cell Research
|
February 21, 2026
Generation of human induced pluripotent stem cell lines carrying a heterozygous and homozygous PRKD1 c.1774G > A genetic variant causing syndromic congenital defects
Fabian Witthoff, Niels Pietsch, Philipp Henning, et al.
BMJ Open
|
March 5, 2025
Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X)
Michael E Weinblatt, Peter C Taylor, Iain B McInnes, et al.
Journal of the American Chemical Society
|
October 4, 2024
Enhanced Benzene Adsorption in Chloro-Functionalized Metal-Organic Frameworks
Yu Han, David Brooks, Meng He, et al.
Global Health Action
|
March 28, 2012
DengueTools: innovative tools and strategies for the surveillance and control of dengue
Annelies Wilder-Smith, Karl-Erik Renhorn, Hasitha Tissera, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 21, 2009
The risk of exaggerated risk aversion-a life and death struggle for molecular imaging
Bengt Långström, Anders Grahnen, Per Hartvig Honoré, et al.
Annals of the Rheumatic Diseases
|
September 11, 2023
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3)
Peter C Taylor, Michael E Weinblatt, Iain B McInnes, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Human Mutation
|
September 5, 2003
Mutation spectrum of human SLC39A4 in a panel of patients with acrodermatitis enteropathica
Sébastien Küry, Monia Kharfi, Ridha Kamoun, et al.
Journal of Clinical Microbiology
|
January 9, 2015
Early detection of dengue virus by use of reverse transcription-recombinase polymerase amplification
Boon-Teong Teoh, Sing-Sin Sam, Kim-Kee Tan, et al.
Nanoscale
|
March 19, 2020
Inkjet-printed graphene Hall mobility measurements and low-frequency noise characterization
Gabriele Calabrese, Lorenzo Pimpolari, Silvia Conti, et al.
Patterns (New York, N.Y.)
|
September 10, 2025
A view of the sustainable computing landscape
Benjamin C Lee, David Brooks, Arthur van Benthem, et al.
Stem Cell Research
|
February 21, 2026
Generation of human induced pluripotent stem cell lines carrying a heterozygous and homozygous PRKD1 c.1774G > A genetic variant causing syndromic congenital defects
Fabian Witthoff, Niels Pietsch, Philipp Henning, et al.
BMJ Open
|
March 5, 2025
Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X)
Michael E Weinblatt, Peter C Taylor, Iain B McInnes, et al.
Journal of the American Chemical Society
|
October 4, 2024
Enhanced Benzene Adsorption in Chloro-Functionalized Metal-Organic Frameworks
Yu Han, David Brooks, Meng He, et al.
Global Health Action
|
March 28, 2012
DengueTools: innovative tools and strategies for the surveillance and control of dengue
Annelies Wilder-Smith, Karl-Erik Renhorn, Hasitha Tissera, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 21, 2009
The risk of exaggerated risk aversion-a life and death struggle for molecular imaging
Bengt Långström, Anders Grahnen, Per Hartvig Honoré, et al.
Annals of the Rheumatic Diseases
|
September 11, 2023
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3)
Peter C Taylor, Michael E Weinblatt, Iain B McInnes, et al.
Page
of 8